Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $53,328 - $63,635
-1,100 Reduced 20.0%
4,400 $225,000
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $5,363 - $6,252
-100 Reduced 1.79%
5,500 $343,000
Q3 2021

Oct 13, 2021

BUY
$59.17 - $69.31 $5,917 - $6,931
100 Added 1.82%
5,600 $331,000
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $8,901 - $10,011
-150 Reduced 2.65%
5,500 $347,000
Q2 2020

Jul 29, 2020

SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 1.74%
5,650 $332,000
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $266,800 - $387,722
5,750 New
5,750 $321,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mattern Wealth Management LLC Portfolio

Follow Mattern Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mattern Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mattern Wealth Management LLC with notifications on news.